SCHEMBL30427442

SCHEMBL30427442

CC(C)(C)OC(=O)NC1CN(c2nc(C=O)ccc2F)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 3/20 0.45
▸ MAP4K4 O95819 2/20 0.39
▸ CKS1B P61024 1/20 0.39
▸ SKP1 P63208 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ PIM3 Q86V86 1/20 0.38
▸ PIM2 Q9P1W9 1/20 0.38
▸ PDE2A O00408 1/20 0.38
▸ EIF2AK4 Q9P2K8 1/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ ENPP2 Q13822 1/20 0.36
▸ NR1H2 P55055 1/20 0.36
▸ CTSK P43235 2/20 0.36
▸ TRPV1 Q8NER1 2/20 0.36
▸ KDM4D Q6B0I6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30427246 0.82 PDE10A (0.45) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL25190170 0.82 GRM4 (0.36) —
SCHEMBL15401351 0.75 BTK (0.55) PDE10AMAP4K4JAK3BTKKDM4D
SCHEMBL24541862 0.74 PDE10A (0.43) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL29952159 0.72 PIM1 (0.44) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL4476430 0.72 PDE10A (0.46) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL29954510 0.72 PIM1 (0.55) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL24951335 0.71 PDE10A (0.56) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL30819455 0.71 PDE10A (0.56) PDE10AMAP4K4CKS1BSKP1SKP2
SCHEMBL30202103 0.71 PDE10A (0.56) PDE10AMAP4K4CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024232597-A1 4-CHROMANONE COMPOUNDS THAT DEGRADE WDR5 AND USES THEREOF 엘젠테라퓨틱스 주식회사 2024-11-14 — — WO disclosed
WO-2023090829-A1 LOW-MOLECULAR-WEIGHT COMPOUND FOR REGULATING MLL1-WDR5 INTERACTION AND USE THEREOF 엘젠테라퓨틱스 주식회사 2023-05-25 — — WO disclosed
Send feedback